Search details
1.
Race and ethnicity: Risk factors for fungal infections?
PLoS Pathog
; 19(1): e1011025, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36602962
2.
Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region.
Med Mycol
; 61(10)2023 Oct 05.
Article
in English
| MEDLINE | ID: mdl-37804176
3.
Effect of coccidioidomycosis prophylaxis in selecting non-Candida albicans species amongst solid organ transplant recipients in Arizona.
Mycoses
; 66(3): 237-241, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36401812
4.
Evolution of Cefiderocol Non-Susceptibility in Pseudomonas aeruginosa in a Patient Without Previous Exposure to the Antibiotic.
Clin Infect Dis
; 73(11): e4472-e4474, 2021 12 06.
Article
in English
| MEDLINE | ID: mdl-33411899
5.
Remarks on the Universal Lifelong Coccidioidomycosis Prophylaxis in Lung Transplant Recipients.
Clin Infect Dis
; 74(10): 1885-1886, 2022 05 30.
Article
in English
| MEDLINE | ID: mdl-34738618
6.
Diagnostic Approach to Coccidioidomycosis in Solid Organ Transplant Recipients.
J Fungi (Basel)
; 9(5)2023 Apr 26.
Article
in English
| MEDLINE | ID: mdl-37233224
7.
Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis.
Open Forum Infect Dis
; 10(8): ofad345, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37539063
8.
The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab-Cilgavimab (Evusheld): Real-World Experience at a Large Academic Center.
Am J Med
; 136(1): 96-99, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36181789
9.
The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era.
Am J Med
; 136(6): 577-584, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36898600
10.
The Utility of (1â3)-ß-D-Glucan Testing in the Diagnosis of Coccidioidomycosis in Hospitalized Immunocompromised Patients.
J Fungi (Basel)
; 8(8)2022 Jul 25.
Article
in English
| MEDLINE | ID: mdl-35893136
11.
Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection.
Open Forum Infect Dis
; 9(7): ofac186, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35791354
12.
Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action.
Expert Opin Investig Drugs
; 31(8): 795-812, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35657026
14.
Progressive headache in a 48-year-old man.
BMJ Case Rep
; 20152015 Jan 09.
Article
in English
| MEDLINE | ID: mdl-25576515
Results
1 -
14
de 14
1
Next >
>>